Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution
Breast cancers that are “triple-negative” for the clinical markers ESR1, PGR, and HER2 typically belong to the Basal-like molecular subtype. Defective Rb, p53, and Brca1 pathways are each associated with triple-negative and Basal-like subtypes. Our mouse genetic studies demonstrate that the combined...
Main Authors: | Kumar, Prashant, Mukherjee, Malini, Johnson, Jacob P. S., Patel, Milan, Huey, Bing, Albertson, Donna G., Simin, Karl |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500050/ |
Similar Items
-
pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia
by: Simin, Karl, et al.
Published: (2004) -
Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
by: Johnson, SM, et al.
Published: (2000) -
Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
by: McAllister, Kimberly A, et al.
Published: (2002) -
The cooperative effect of p53 and Rb in local nanotherapy in a rabbit VX2 model of hepatocellular carcinoma
by: Dong, Shengli, et al.
Published: (2013) -
brca2 and tp53 Collaborate in Tumorigenesis in Zebrafish
by: Shive, Heather R., et al.
Published: (2014)